In the present study, vildagliptin treatment for 4 weeks effectively alleviated prediabetes and hyperlipidemia, as indicated by decreases in plasma insulin, HOMA index, plasma total cholesterol, and plasma low‐density lipoprotein levels (Table 1). The gene discussed is INS; the disease is hyperlipidemia.